Showing results (231-240 of 260) with videos related to
Sort By:
Pageof 26
Genome Biology|November 24, 2023
Acute expression of human APOBEC3B in mice results in RNA editing and lethalityAlicia Alonso de la Vega, Nuri Alpay Temiz, Rafail Tasakis, et al.Cell Chemical Biology|January 8, 2025
Targeting N-Myc in neuroblastoma with selective Aurora kinase A degradersJian Tang, Ramkumar Moorthy, Laura E Hirsch, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 27, 2016
APOBEC3G Expression Correlates with T-Cell Infiltration and Improved Clinical Outcomes in High-grade Serous Ovarian CarcinomaBrandon Leonard, Gabriel J Starrett, Matthew J Maurer, et al.Nature|December 23, 2011
Vif hijacks CBF-β to degrade APOBEC3G and promote HIV-1 infectionStefanie Jäger, Dong Young Kim, Judd F Hultquist, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 16, 2020
The DNA Cytosine Deaminase APOBEC3B is a Molecular Determinant of Platinum Responsiveness in Clear Cell Ovarian CancerArtur A Serebrenik, Prokopios P Argyris, Matthew C Jarvis, et al.Cancer Immunology Research|April 4, 2019
Suboptimal T-cell Therapy Drives a Tumor Cell Mutator Phenotype That Promotes Escape from First-Line TreatmentLaura Evgin, Amanda L Huff, Timothy Kottke, et al.Biorxiv : the Preprint Server for Biology|October 9, 2023
A comprehensive study of SARS-CoV-2 main protease (Mpro) inhibitor-resistant mutants selected in a VSV-based systemFrancesco Costacurta, Andrea Dodaro, David Bante, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 7, 2018
Lobular Carcinomas In Situ Display Intralesion Genetic Heterogeneity and Clonal Evolution in the Progression to Invasive Lobular CarcinomaJu Youn Lee, Michail Schizas, Felipe C Geyer, et al.Journal of Medicinal Chemistry|September 11, 2025
Azapeptide-Based SARS-CoV-2 Main Protease Inhibitors: Design, Synthesis, Enzyme Inhibition, Structural Determination, and Antiviral ActivityPhilipp Flury, Jyoti Vishwakarma, Katharina Sylvester, et al.Elife|March 24, 2023
Evidence for virus-mediated oncogenesis in bladder cancers arising in solid organ transplant recipientsGabriel J Starrett, Kelly Yu, Yelena Golubeva, et al.Pageof 26